共 50 条
- [35] Adverse Events During Single-Agent Phase of Venetoclax Therapy CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S358
- [36] Phase II study of single-agent nivolumab in patients with myelofibrosis Annals of Hematology, 2021, 100 : 2957 - 2960
- [38] Safety profile of single-agent carfilzomib in patients with relapsed or refractory multiple myeloma from 4 phase ll trials ONKOLOGIE, 2013, 36 : 39 - 40